CALL FOR PAPERS

CERTIFICATE

IMPACT FACTOR 2021

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

 

 

 

 

Effect of pre-treatment prior to antagonist regimen on clinical outcome of expected poor ovarian reserves patients using poseidon criteria

Author: 
Dr. Anjali Chaudhary , Dr. Umesh Varma, Dr. Shubhra Jaiswal, Dr. Praveen Upadhyay, Aditya Varma and Dr. Kanika Gupta
Subject Area: 
Health Sciences
Abstract: 

PURPOSE: The study is aimed to analyse the effect of different pre-treatments on the IVF outcome of expected poor ovarian responders patients according to POSEIDON criteria. Method: Retrospective analysis of 364 cycles of expected POR patients who had IVF-ET from jan18 to jan20. Pre-treatment was given prior to gonadotrophins stimulation. The cycle were divided into OCP group A (N=167), estradiol valerate group B (N=56), no pre-treatment group C, (N= 141). Result: Demographic profile and controlled ovarian stimulation were nearly same for all POR patients where antagonist protocol was used with recombinant HCG for trigger and progesterone supplement in luteal phase. The Implantation rate was higher in Group A (26.2%) and in Group B (26.8%) as compared in Group C 14.5% (p 0.001).The clinical pregnancy was higher in Group A 36.1% and in Group B 42% as compared to Group C 21.2% (p 0.001). The abortion rate was lowest in Group A 11.4% as compared to 28.6% in Group B and 35.5% in Group C. Although biochemical pregnancy rate was lowest in Group B 19.6% as compared to Group A 31.1% and in Group C 34.0%. Conclusion: Pre-treatment prior to GnRh antagonist regimen in expected POR patient with OCP or estradiol valerate in luteal phase can improve clinical pregnancy outcome of POR patients. Estradiol valerate seems to be more effective than OCP. Although it may be associated with longer stimulation and higher gonadotropin consumption.

PDF file: 

Announcement

INTERNATIONAL JOURNAL OF CURRENT RESEARCH

FAST PUBLICATION : JULY 2022
IMPACT FACTOR: 7.992

Journal website: ...

IJMCE RECOMMENDATION

ONLINE PAYPAL PAYMENT

CURRENT ISSUE

NEWS

CHIEF EDITOR
Rosane Cavalcante Fragoso, Brasil
ASSOCIATE CHIEF EDITOR

   

Jean-Marc SABATIER
Chief Scientific Officer and Head of a Research Group
France

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

EDITORIAL BOARD

Dr. Abdul Hannan Abdul Mannan Shaikh
Saudi Arabia.
Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran